Apollo Capital releases MediPharm activist plan
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Medipharm Labs Corp (LABS)
Medipharm Labs Corp stock price live, this page displays TSX LABS stock exchange data. View the LABS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Medipharm Labs Corp real time stock price chart below.
What Is the Medipharm Labs Corp Stock Price Today?
The Medipharm Labs Corp stock price today is 0.07.
What Is the Stock Symbol for Medipharm Labs Corp?
The stock symbol for Medipharm Labs Corp is ""LABS.""
What Stock Exchange Does Medipharm Labs Corp Trade On?
Medipharm Labs Corp is listed and trades on the Toronto stock exchange.
Is Medipharm Labs Corp a Good Stock to Buy?
Determining whether Medipharm Labs Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LABS quote. (ISIN: CA58504D1006)
What Is the Medipharm Labs Corp Stock Price Today?
The Medipharm Labs Corp stock price today is 0.07.
What Is the Stock Symbol for Medipharm Labs Corp?
The stock symbol for Medipharm Labs Corp is ""LABS.""
What Stock Exchange Does Medipharm Labs Corp Trade On?
Medipharm Labs Corp is listed and trades on the Toronto stock exchange.
Is Medipharm Labs Corp a Good Stock to Buy?
Determining whether Medipharm Labs Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LABS quote. (ISIN: CA58504D1006)
0.07
0.00(0.00%)
Real-time Data·
Fair Value
An estimate of a Medipharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.07
0.07
52 wk Range
0.06
0.12
LABS Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
LABS is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Medipharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.070.07
52 wk Range
0.060.12
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
LABS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Medipharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Neutral
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
- MediPharm responds to Apollo allegations
- Investing.com
- Apollo Capital releases MediPharm activist plan
- Investing.com
- MediPharm responds to Apollo allegations
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Medipharm Labs Corp Company Profile
MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, develops, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis products. In addition, the company offers cannabis related medical information and services; and medical cannabis clinic services. MediPharm Labs Corp. was founded in 2015 and is based in Barrie, Canada.
Medipharm Labs Corp Earnings Call Summary for Q1/2025
- Medipharm Labs reported Q1 2025 revenue of $10.8M (+10.6% YoY), with first positive adjusted EBITDA of $141K in over 5 years
- International medical cannabis revenue surged 87% to $5.9M; company maintains $8.4M cash balance with virtually no debt
- Stock price rose 10.53% to $0.11 in pre-market trading despite missing $11.4M revenue forecast
- Management expects continued growth in international business, exploring M&A opportunities while maintaining profitability
- CEO highlighted complexity of international medical cannabis market regulations as potential challenge for expansion
Last Updated: 14/05/2025, 15:54
Read Full TranscriptCompare LABS to Peers and Sector
Metrics to compare | LABS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLABSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.9x | −1.0x | −0.5x | |
PEG Ratio | −0.08 | 0.01 | 0.00 | |
Price/Book | 0.7x | 0.7x | 2.6x | |
Price / LTM Sales | 0.7x | 1.0x | 3.2x | |
Upside (Analyst Target) | - | 47.2% | 40.5% | |
Fair Value Upside | Unlock | 19.8% | 4.4% | Unlock |
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 0.00
Earnings
Latest Release
May 14, 2025
EPS / Forecast
-- / -0.003
Revenue / Forecast
10.81M / 11.40M
FAQ
What Stock Exchange Does Medipharm Trade On?
Medipharm is listed and trades on the Toronto Stock Exchange stock exchange.
What Is the Stock Symbol for Medipharm?
The stock symbol for Medipharm is "LABS."
What Is the Medipharm Market Cap?
As of today, Medipharm market cap is 29.06M.
What Is Medipharm's Earnings Per Share (TTM)?
The Medipharm EPS (TTM) is -0.02.
When Is the Next Medipharm Earnings Date?
Medipharm will release its next earnings report on 17 Aug 2025.
From a Technical Analysis Perspective, Is LABS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Medipharm Stock Split?
Medipharm has split 1 times.
How Many Employees Does Medipharm Have?
Medipharm has 161 employees.
What is the current trading status of Medipharm (LABS)?
As of 25 Jul 2025, Medipharm (LABS) is trading at a price of 0.07, with a previous close of 0.07. The stock has fluctuated within a day range of 0.07 to 0.07, while its 52-week range spans from 0.06 to 0.12.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.